References
- Williams I, Wheatcroft S, Shah A, et al. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes. 2002;26:754–764.
- Lundberg J, Weitzberg E, Gladwin M. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7:156–167.
- Senkus KE, Crowe-White KM. Influence of mouth rinse use on the enterosalivary pathway and blood pressure regulation: a systematic review. Crit Rev Food Sci Nutr. 2019Sep;23:1–13.
- [cited 2020 Sep 24]. Available from: https://www.ada.org/en/member-center/oral-health-topics/mouthrinse.
- Joshipura KJ, Muñoz-Torres FJ, Morou-Bermudez E, et al. Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. Nitric Oxide - Biol Chem. 2017;71:14–20.
- Joshipura K, Muñoz-Torres F, Fernández-Santiago J, et al. Over-the-counter mouthwash use, nitric oxide and hypertension risk. Blood Press. 2020;29(2):103–112.
- Bryan NS, Tribble G, Angelov N. Oral microbiome and nitric oxide: the missing link in the management of blood pressure. Curr Hypertens Rep. 2017 Apr;19(4):33. PMID: 28353075.
- Goh CE, Trinh P, Colombo PC, et al. Association between nitrate‐reducing oral bacteria and cardiometabolic outcomes: results from ORIGINS. J Am Heart Assoc. 2019 Dec 3;8(23):e013324.